RxDoctor Payments Data

Peggy Phillips, NP

Family · Grafton, WVNPI 1912993510

Payments from drug & device makers

$445in general payments, 2019–2025

Across 23 payments — averaging $19.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$241
  • Novo Nordisk$40
  • AstraZeneca$30
  • Pharmacosmos Therapeutics Inc.$23
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$21
  • Novartis$19
  • plus $71 from 4 others

What the payments were for

  • Food & beverage$445100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$445 in reported general payments places this provider in the 50th percentile of 1,507 family providers in West Virginia.

See all family providers in West Virginia

Medicare billing

Part B allowed, 2024
$26,247
Medicare patients
114
Services billed
1,204

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide80$126,038
OzempicSemaglutide27$43,690
JanuviaSitagliptin Phosphate17$24,805
FarxigaDapagliflozin Propanediol17$24,368
EliquisApixaban12$19,843
TradjentaLinagliptin20$12,998
VascepaIcosapent Ethyl17$9,967
SymbicortBudesonide/Formoterol Fumarate26$7,516
JanumetSitagliptin Phos/Metformin Hcl11$6,090
Albuterol Sulfate HfaAlbuterol Sulfate78$2,535
Levothyroxine Sodium186$1,944
Fluticasone Propionate189$1,935
Epinephrine11$1,723
Rosuvastatin Calcium113$1,669
Gabapentin83$1,565

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$40$43,69027 claims
AstraZenecaFarxiga, Symbicort$30$31,88443 claims
PfizerEliquis$18$19,84312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 1,507 family providers in West Virginia.

Other family in Grafton

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →